PT - JOURNAL ARTICLE AU - Gulsah Tuncer AU - Serkan Surme AU - Osman Faruk Bayramlar AU - Hatice Kubra Karanalbant AU - Betul Copur AU - Meltem Yazla AU - Esra Zerdali AU - Inci Yilmaz Nakir AU - Ayse Kurt Cinar AU - Ahmet Buyukyazgan AU - Hatice Balli AU - Yesim Kurekci AU - Serap Simsek Yavuz AU - Mehmet Mesut Sonmez AU - Gonul Sengoz AU - Filiz Pehlivanoglu TI - NEWS2 and laboratory predictors correlated with clinical deterioration in hospitalised patients with COVID-19 AID - 10.1101/2021.01.17.21249878 DP - 2021 Jan 01 TA - medRxiv PG - 2021.01.17.21249878 4099 - http://medrxiv.org/content/early/2021/01/20/2021.01.17.21249878.short 4100 - http://medrxiv.org/content/early/2021/01/20/2021.01.17.21249878.full AB - Background We aimed to determine prognostic values of NEWS2 and laboratory parameters during the first week of COVID-19.Methods All adult patients who were hospitalized for a confirmed COVID-19 between the 11th of March and the 11th of May 2020 were retrospectively included. To evaluate the factors in prognosis which are admission to intensive care unit (ICU) and in-hospital death, univariate logistic regression analysis was performed at admission (D0), at day-3 (D3), day-5 (D5), and day-7 (D7). Additionally, receiver operating characteristic (ROC) analyses were performed.Results Overall, 611 patients were included. Clinical deterioration was observed in 79 (12.9%) patients during hospitalisation, 36 (5.9%) during the first three days, 54 (8.8%) during the first five days, and 62 (10.1%) during the first week of hospitalisation. Our results showed that NEWS2, procalcitonin, neutrophil/lymphocyte ratio (NLR), and albumin were the best predictors for clinical deterioration at D0, D3, D5, and D7. Procalcitonin had the highest odds ratio for clinical deterioration on all days in univariate analysis. ROC analyses showed that NEWS2 at D7, procalcitonin at D5, albumin at D7, and NLR at D5 had highest AUC values. Additionally, we detected a strong correlation between NEWS2 and laboratory parameters including neutrophil, lymphocyte, NLR, platelet/lymphocyte ratio, CRP, procalcitonin, ferritin, and urea on all days.Conclusion This study provides a list of several laboratory parameters correlated with NEWS2 and potential predictors for ICU admission or in-hospital death during the clinical course of COVID-19. Dynamic monitoring of NEWS2 and laboratory parameters is vital for improving clinical outcomes.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research did not receive any specific grant. No funding was used.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All procedures performed in studies involving human participants were in accordance with the ethical standards of the Declaration of Helsinki. This study was approved by the Ethics Committee of Haseki Training and Research Hospital and the national research committee. Written informed consent was waived, given the retrospective nature of this study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available from the corresponding author upon reasonable request.